Mead Johnson Nutrition Company (MJN) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Mead Johnson Nutrition Company (MJN) Issues Quarterly  Earnings Results, Misses Estimates By $0.03 EPS

Mead Johnson Nutrition Company (NYSE:MJN) posted its quarterly earnings results on Thursday. The company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $0.81 by $0.03. Mead Johnson Nutrition Company had a negative return on equity of 122.64% and a net margin of 14.56%. The firm had revenue of $901.60 million for the quarter, compared to analyst estimates of $928.84 million. During the same period last year, the company posted $0.78 earnings per share. The firm’s quarterly revenue was down 6.8% compared to the same quarter last year. Mead Johnson Nutrition Company updated its FY17 guidance to $3.35-3.50 EPS.

Shares of Mead Johnson Nutrition Company (NYSE:MJN) opened at 71.24 on Monday. The company has a 50 day moving average price of $72.20 and a 200 day moving average price of $78.59. The company has a market capitalization of $13.14 billion, a PE ratio of 24.40 and a beta of 1.40. Mead Johnson Nutrition Company has a 1-year low of $66.66 and a 1-year high of $94.40.

The firm also recently announced a quarterly dividend, which was paid on Friday, January 6th. Investors of record on Friday, December 23rd were paid a $0.4125 dividend. The ex-dividend date was Wednesday, December 21st. This represents a $1.65 annualized dividend and a dividend yield of 2.32%. Mead Johnson Nutrition Company’s payout ratio is presently 56.31%.

Several hedge funds have recently made changes to their positions in the stock. Penserra Capital Management LLC raised its stake in Mead Johnson Nutrition Company by 96.1% in the third quarter. Penserra Capital Management LLC now owns 1,373 shares of the company’s stock worth $108,000 after buying an additional 673 shares during the period. FNY Managed Accounts LLC bought a new position in shares of Mead Johnson Nutrition Company during the third quarter worth approximately $125,000. Pinkerton Retirement Specialists LLC bought a new position in shares of Mead Johnson Nutrition Company during the second quarter worth approximately $128,000. Feltz Wealth PLAN Inc. bought a new position in shares of Mead Johnson Nutrition Company during the second quarter worth approximately $180,000. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of Mead Johnson Nutrition Company by 118.2% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 2,400 shares of the company’s stock worth $190,000 after buying an additional 1,300 shares in the last quarter. Hedge funds and other institutional investors own 95.22% of the company’s stock.

Several analysts have recently commented on MJN shares. Citigroup Inc. reissued a “buy” rating and issued a $90.00 price objective on shares of Mead Johnson Nutrition Company in a research note on Tuesday, November 1st. Deutsche Bank AG reaffirmed a “hold” rating and issued a $88.00 target price (up from $85.00) on shares of Mead Johnson Nutrition Company in a report on Friday, October 21st. Credit Suisse Group set a $95.00 price objective on Mead Johnson Nutrition Company and gave the company a “buy” rating in a report on Wednesday, October 12th. lowered Mead Johnson Nutrition Company from an “outperform” rating to an “underperform” rating and set a $77.00 price objective for the company. in a report on Friday, October 28th. Finally, J P Morgan Chase & Co lowered Mead Johnson Nutrition Company from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $90.00 to $75.00 in a report on Friday, October 28th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Mead Johnson Nutrition Company presently has an average rating of “Hold” and an average target price of $86.62.

Mead Johnson Nutrition Company Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Related posts

Leave a Comment